atenolol and sq-11725

atenolol has been researched along with sq-11725 in 97 studies

Research

Studies (97)

Timeframe	Studies, this research(%)	All Research%
pre-1990	38 (39.18)	18.7374
1990's	20 (20.62)	18.2507
2000's	18 (18.56)	29.6817
2010's	19 (19.59)	24.3611
2020's	2 (2.06)	2.80

Authors

Authors	Studies
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H	1
Topliss, JG; Yoshida, F	1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Baker, JG	1
Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chuang, S; Horne, J; Porter, CJ; Scanlon, MJ; Velkov, T	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Bard, B; Carrupt, PA; Martel, S	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S	1
Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Avdeef, A; Tam, KY	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Bellman, K; Knegtel, RM; Settimo, L	1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL	1
Lipworth, BJ; McDevitt, DG; Wheeldon, NM	3
Bousser, MG; Massiou, H	1
Hirakawa, S; Imai, Y; Ito, H; Kakami, M; Koshiji, M; Minatoguchi, S; Watanabe, H	1
Almotrefi, AA; Dzimiri, N	1
Murano, M; Naruto, S; Noguchi, H; Yoshida, K	1
Allavena, A; Brambilla, G; Gazzaniga, GM; Martelli, A; Mazzei, M; Robbiano, L	1
Irvine, NA; Lipworth, BJ; McDevitt, DG	1
Cherchi, A; Sau, F; Seguro, C	1
Brammell, HL; Hiatt, WR; Horwitz, LD; Travis, V; Wolfel, EE	1
Kostis, JB	2
Bertino, JS; Corsi, CM; Nafziger, AN; Pieper, JA	1
Cleroux, J; Leenen, FH; Taylor, AW; Van Nguyen, P	1
From, RP; Mehta, MP; Pathak, D	1
Brammell, HL; Hiatt, WR; Horwitz, LD; Nies, AS; Stoll, S; Wolfel, EE; Zerbe, GO	1
Fletcher, GF	1
McDevitt, DG	1
Ansuini, R; Belogi, M; Gaggi, S; Pupita, F; Pupita, G	1
Fishbein, L; Jackson, CD	1
Charyev, KhE; Iurenev, AP; Shkhvatsabaia, IK	1
Baylor, P; Fildes, J; Gerst, PH; Zonszein, J	1
Epstein, M; Oster, JR	1
Brammell, HL; Carry, MR; Hiatt, WR; Horwitz, LD; Ringel, SP; Travis, V; Wolfel, EE	1
Burris, JF; Goldstein, J; Plachetka, JR; Sirgo, MA; Sutton, JM; Zager, PG	1
Alexopoulos, D; Cobbe, SM; Manley, BS; Robinson, GJ	1
Harvengt, C; Heller, FR; Martiat, P; Van Nieuwenhuyze, Y	1
Bonsignore, MR; Culver, PL; Dodek, PM; Jerome, EH; Staub, NC	1
Coelho, J; Garg, DC; Hitzenberger, G; Irwin, C; Kaik, G; Klausner, MA; Magometschnigg, D; Mullane, JF; Ventura, DF; Weidler, DJ	1
Cox, DA; Leader, JP; Milson, JA; Singleton, W	1
Vidt, DG	1
Frishman, WH; Koch-Weser, J	1
Burmeister, WE; Lee, RJ; Reynolds, RD	1
Mattioli, G; Menozzi, A; Ricci, S; Teglio, V	1
Hampton, JR; Wilcox, RG	1
Iskandrian, AS; Kotler, MN; Segal, BL	1
Fregly, MJ	1
Laher, MS; McGarry, K; O'Brien, E; O'Callaghan, WG; O'Malley, K	1
Charyev, KhE; Erina, EV	1
Desiatnichenko, VM; Romakov, AIu; Sagirov, AM; Sobol', IuS; Sumarokov, AB	1
Jackson, EA; Sullman, SA	1
Lucchesi, BR; Patterson, E	1
Chung, DC; Laschuk, MJ	1
Beaulieu, G; Grimes, D; Muirhead, C; Oshiro, G	1
Peele, ME; Shulkin, BL; Utiger, RD	1
McGoon, MD; Vlietstra, RE	1
Cosgrove, NM; Kostis, JB; Krieger, SD; Lacy, CR	1
Abed, J; Donaldson, R; Nashat, F; Taggart, P	1
Anderson, S; Brater, DC; Kaplan, NM; Ram, CV	1
Beebe, HG; Messina, LM; Moursi, MM; Stanley, JC; Welling, TH	1
Dykstra, LA; Fecho, K; Lysle, DT	1
Kurosawa, H; Taira, N; Yanagisawa, T	1
Davies, RA; Fourney, A; Leenen, FH	1
de Castro, B; Gameiro, P; Guimarães, C; Lima, JL; Reis, S	2
Azevedo, ER; Newton, GE; Parker, JD	1
Belhassen, B; Dorostkar, PC; Eldar, M; Scheinman, MM	1
Andrews, ML; Benhorin, J; Crampton, RS; Hall, WJ; Locati, EH; Medina, A; Moss, AJ; Napolitano, C; Priori, SG; Robinson, JL; Schwartz, PJ; Timothy, K; Towbin, JA; Vincent, GM; Zareba, W; Zhang, L	1
Chauhan, V; Hegele, RA; Klein, GJ; Krahn, AD; Skanes, AC; Wang, J; Yee, R	1
Andersson, KK; Barra, AL; Engalytcheff, A; Kolberg, M; Tilquin, B	1
Al-Ghannam, SM	1
DE Magalhaes, LP; Fagundes, A; Russo, M; Xavier, E	1
Massarsky, A; Moon, TW; Trudeau, VL	1
Cooper, WJ; Song, W; Wang, L; Xu, H	1
Figueroa, JJ; Fischer, PR; Gehrking, JA; Iodice, V; Kimpinski, K; Low, PA; Opfer-Gehrking, TL; Sandroni, P; Singer, W; Sletten, DM	1
Abu-Zeitone, A; McNitt, S; Moss, AJ; Peterson, DR; Polonsky, B	1
Fruge, JH; Massengale, WT; Rouhana, HF	1
Demir, Y	1
Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H	1
Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C	1

Reviews

11 review(s) available for atenolol and sq-11725

Article	Year
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists. Journal of medicinal chemistry, 1988, Volume: 31, Issue:11 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship	1988
[Beta-blockers and migraine]. Pathologie-biologie, 1992, Volume: 40, Issue:4 Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol	1992
A toxicological review of beta-adrenergic blockers. Fundamental and applied toxicology : official journal of the Society of Toxicology, 1986, Volume: 6, Issue:3 Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol	1986
Beta blockers and renal function: a reappraisal. Journal of clinical hypertension, 1985, Volume: 1, Issue:1 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Urea Nitrogen; Cardiac Output; Creatinine; Dogs; Glomerular Filtration Rate; Heart; Humans; Hypertension; Kidney; Labetalol; Metoprolol; Nadolol; Propanolamines; Propranolol; Renal Circulation; Renin; Sympathomimetics; Vascular Resistance	1985
Advances in the medical management of renovascular hypertension. The Urologic clinics of North America, 1984, Volume: 11, Issue:3 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol	1984
beta-Adrenoceptor antagonists: new drugs and new indications. The New England journal of medicine, 1981, Aug-27, Volume: 305, Issue:9 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Metoprolol; Migraine Disorders; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol	1981
[Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies]. Minerva cardioangiologica, 1982, Volume: 30, Issue:3 Topics: Adrenergic beta-Antagonists; Atenolol; Female; Hemodynamics; Humans; Hypertension; Male; Metoprolol; Nadolol; Pindolol; Propanolamines	1982
Comparative review of beta-blocking agents. Connecticut medicine, 1984, Volume: 48, Issue:4 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; Metoprolol; Migraine Disorders; Myocardial Infarction; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol	1984
The new beta-adrenergic antagonists. Canadian Anaesthetists' Society journal, 1984, Volume: 31, Issue:4 Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Labetalol; Metoprolol; Nadolol; Oxprenolol; Pindolol; Propanolamines; Timolol	1984
β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms. Journal of experimental zoology. Part A, Ecological genetics and physiology, 2011, Jun-01, Volume: 315, Issue:5 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Endocrine Disruptors; Fishes; Gluconeogenesis; Glucose; Glycogenolysis; Insulin; Insulin Secretion; Lipolysis; Metoprolol; Molecular Structure; Mollusca; Muscle Contraction; Nadolol; Propranolol; Species Specificity; Water Pollutants, Chemical	2011
Beta blocker treatment for infantile hemangiomas. Dermatology online journal, 2015, Jul-15, Volume: 21, Issue:7 Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Nadolol; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2015

Trials

22 trial(s) available for atenolol and sq-11725

Article	Year
Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects. British journal of clinical pharmacology, 1992, Volume: 34, Issue:4 Topics: Adult; Atenolol; Celiprolol; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Nadolol; Physical Exertion; Potassium; Receptors, Adrenergic, beta; Single-Blind Method; Tremor	1992
[Beta-blockers and migraine]. Pathologie-biologie, 1992, Volume: 40, Issue:4 Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol	1992
A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol. European journal of clinical pharmacology, 1991, Volume: 40, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisoprolol; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Male; Nadolol; Propanolamines; Single-Blind Method; Statistics as Topic; Tremor	1991
Plasma catecholamine responses to exercise after training with beta-adrenergic blockade. Journal of applied physiology (Bethesda, Md. : 1985), 1990, Volume: 68, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Epinephrine; Exercise; Humans; Male; Nadolol; Norepinephrine; Physical Education and Training	1990
Beta-blocker duration of action and implications for therapy. The American journal of cardiology, 1990, Nov-06, Volume: 66, Issue:16 Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Circadian Rhythm; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Nadolol; Pindolol	1990
Lack of effect of atenolol and nadolol on the metabolism of theophylline. British journal of clinical pharmacology, 1990, Volume: 29, Issue:2 Topics: Adult; Atenolol; Drug Interactions; Half-Life; Humans; Male; Nadolol; Smoking; Theophylline	1990
Effects of beta 1- vs. beta 1 + beta 2-blockade on exercise endurance and muscle metabolism in humans. Journal of applied physiology (Bethesda, Md. : 1985), 1989, Volume: 66, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Catecholamines; Clinical Trials as Topic; Double-Blind Method; Glycogen; Hemodynamics; Humans; Male; Muscles; Nadolol; Physical Endurance; Potassium; Triglycerides	1989
beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol. Clinical pharmacology and therapeutics, 1985, Volume: 37, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Epinephrine; Heart Rate; Humans; Leg; Male; Nadolol; Propanolamines; Random Allocation; Vascular Resistance	1985
Beta-blockers and psychometric performance: studies in normal volunteers. European journal of clinical pharmacology, 1985, Volume: 28 Suppl Topics: Adrenergic beta-Antagonists; Atenolol; Diazepam; Dose-Response Relationship, Drug; Humans; Lipid Metabolism; Nadolol; Oxazepam; Propanolamines; Propranolol; Psychometrics; Psychomotor Performance; Random Allocation; Reaction Time; Reference Values; Solubility; Time Factors	1985
Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease. International journal of clinical pharmacology research, 1985, Volume: 5, Issue:6 Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Female; Heart Diseases; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nadolol; Oxprenolol; Propanolamines; Risk	1985
Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning. Circulation, 1986, Volume: 74, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Exercise Test; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Muscles; Nadolol; Oxygen Consumption; Physical Education and Training; Plethysmography; Random Allocation	1986
Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol. Journal of clinical hypertension, 1986, Volume: 2, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propranolol	1986
The antihypertensive effects of doxazosin: a clinical overview. British journal of clinical pharmacology, 1986, Volume: 21 Suppl 1 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Kinetics; Male; Metoprolol; Middle Aged; Nadolol; Prazosin; Propanolamines; Random Allocation; Risk; Triglycerides	1986
Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris. The American journal of cardiology, 1988, Dec-01, Volume: 62, Issue:17 Topics: Adult; Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nadolol; Placebos; Random Allocation; Time Factors	1988
Comparison between atenolol and nadolol in essential hypertension at rest and on exercise. British journal of clinical pharmacology, 1982, Volume: 13, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Exercise Test; Heart Rate; Humans; Hypertension; Middle Aged; Nadolol; Peak Expiratory Flow Rate; Physical Exertion; Propanolamines	1982
Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients. British journal of clinical pharmacology, 1983, Volume: 16, Issue:4 Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Renal Circulation	1983
[Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension]. Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1983, Volume: 6, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Echocardiography; Heart; Hemodynamics; Humans; Hypertension; Labetalol; Middle Aged; Nadolol; Propanolamines; Propranolol	1983
Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics. American heart journal, 1984, Volume: 108, Issue:4 Pt 2 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Electrocardiography; Half-Life; Heart Rate; Humans; Kinetics; Male; Nadolol; Physical Exertion; Pindolol; Propanolamines; Time Factors	1984
Do beta 3-adrenoceptors mediate metabolic responses to isoprenaline. The Quarterly journal of medicine, 1993, Volume: 86, Issue:9 Topics: Adult; Atenolol; Basal Metabolism; Fatty Acids, Nonesterified; Female; Glucose; Glycerol; Humans; Insulin; Isoproterenol; Lactates; Lactic Acid; Male; Nadolol; Receptors, Adrenergic, beta; Respiration	1993
Investigation of putative cardiac beta 3-adrenoceptors in man. The Quarterly journal of medicine, 1993, Volume: 86, Issue:4 Topics: Adult; Atenolol; Blood Flow Velocity; Blood Pressure; Female; Heart; Heart Rate; Humans; Isoproterenol; Male; Nadolol; Receptors, Adrenergic, beta; Stimulation, Chemical; Tremor	1993
Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade. Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:5 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Confounding Factors, Epidemiologic; Cross-Over Studies; Double-Blind Method; Epinephrine; Female; Heart; Heart Function Tests; Heart Rate; Heart Transplantation; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Norepinephrine; Stroke Volume	1998
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation, 2000, Feb-15, Volume: 101, Issue:6 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Female; Humans; Infant; Long QT Syndrome; Male; Metoprolol; Nadolol; Propranolol; Survival Analysis	2000

Other Studies

65 other study(ies) available for atenolol and sq-11725

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Cheminformatic models to predict binding affinities to human serum albumin. Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25 Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids	2001
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. British journal of pharmacology, 2005, Volume: 144, Issue:3 Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3	2005
Exploring the role of different drug transport routes in permeability screening. Journal of medicinal chemistry, 2005, Jan-27, Volume: 48, Issue:2 Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Characterization of the drug binding specificity of rat liver fatty acid binding protein. Journal of medicinal chemistry, 2008, Jul-10, Volume: 51, Issue:13 Topics: Anilino Naphthalenesulfonates; Animals; Fatty Acid-Binding Proteins; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Fluorescence; Substrate Specificity	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography. Journal of medicinal chemistry, 2009, May-28, Volume: 52, Issue:10 Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19 Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship	2009
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids. Journal of medicinal chemistry, 2009, Oct-22, Volume: 52, Issue:20 Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9 Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3 Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution	2011
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics. PloS one, 2016, Volume: 11, Issue:10 Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat	2016
A comparison of guanfacine, bunazosin, atenolol and nadolol on blood pressure and plasma noradrenaline responses to cold pressor testing. Clinical and experimental pharmacology & physiology, 1992, Volume: 19, Issue:7 Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Atenolol; Blood Pressure; Cold Temperature; Guanfacine; Humans; Hypertension; Nadolol; Norepinephrine; Quinazolines; Receptors, Adrenergic; Stress, Physiological	1992
Effects of beta-adrenoceptor blockers on mitochondrial ATPase activity in guinea pig heart preparations. European journal of pharmacology, 1992, May-14, Volume: 215, Issue:2-3 Topics: Adenosine Triphosphatases; Adrenergic beta-Antagonists; Animals; Atenolol; Female; Guinea Pigs; In Vitro Techniques; Indenes; Male; Mitochondria, Heart; Nadolol; Propanolamines	1992
Determination of nadolol in serum by high-performance liquid chromatography with fluorimetric detection. Journal of chromatography, 1992, Jan-17, Volume: 573, Issue:2 Topics: Atenolol; Chromatography, High Pressure Liquid; Humans; Nadolol; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet	1992
Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes. Cancer research, 1991, May-01, Volume: 51, Issue:9 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cell Survival; DNA; DNA Damage; DNA Repair; Humans; Liver; Male; Metoprolol; Nadolol; Nitrosamines; Nitrosation; Oxprenolol; Propranolol; Rats; Rats, Inbred Strains; Sodium Nitrite; Sotalol	1991
[Effects of antihypertensive therapy with selective and non-selective beta blocking agents on dimensions and function of the left ventricle]. Cardiologia (Rome, Italy), 1991, Volume: 36, Issue:1 Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Pindolol; Timolol; Ventricular Function	1991
Serum potassium concentrations following succinylcholine in patients undergoing beta-adrenoceptor blocking therapy. Journal of clinical anesthesia, 1989, Volume: 1, Issue:5 Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Heart Rate; Humans; Metoprolol; Middle Aged; Nadolol; Ophthalmic Solutions; Potassium; Propranolol; Succinylcholine; Time Factors; Timolol	1989
Exercise training during chronic beta blockade in cardiovascular disease. The American journal of cardiology, 1985, Apr-26, Volume: 55, Issue:10 Topics: Adrenergic beta-Antagonists; Atenolol; Coronary Artery Bypass; Female; Heart Rate; Humans; Male; Metoprolol; Myocardial Infarction; Nadolol; Physical Exertion; Propanolamines; Propranolol; Timolol	1985
[Regression of left-ventricular myocardial hypertrophy in patients with hypertension during long-term treatment with beta-adrenergic blockaders]. Kardiologiia, 1986, Volume: 26, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Cardiomegaly; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Time Factors	1986
Long-acting beta-adrenergic antagonists as preparation for surgery in thyrotoxicosis. Archives of surgery (Chicago, Ill. : 1960), 1986, Volume: 121, Issue:7 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Drug Administration Schedule; Female; Graves Disease; Humans; Middle Aged; Nadolol; Premedication; Propanolamines; Pulse; Thyroidectomy; Time Factors	1986
Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol. Cardiovascular research, 1986, Volume: 20, Issue:10 Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Dose-Response Relationship, Drug; Isomerism; Metoprolol; Muscle Contraction; Nadolol; Oxprenolol; Papillary Muscles; Rabbits; Refractory Period, Electrophysiological; Sotalol	1986
Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects. Journal of clinical pharmacology, 1987, Volume: 27, Issue:7 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Apolipoproteins; Atenolol; Humans; Lipids; Lipoprotein Lipase; Lipoproteins; Liver; Male; Nadolol; Pindolol; Propranolol	1987
Effects of beta-adrenergic agents in lungs of normal and air-embolized awake sheep. Journal of applied physiology (Bethesda, Md. : 1985), 1988, Volume: 64, Issue:6 Topics: Adrenergic beta-Agonists; Animals; Atenolol; Blood Pressure; Blood Proteins; Cardiac Output; Embolism, Air; Female; Lung; Lymph; Nadolol; Propranolol; Proteins; Pulmonary Circulation; Reference Values; Sheep	1988
Cardioselectivity of cetamolol compared with atenolol and nadolol. Journal of clinical pharmacology, 1988, Volume: 28, Issue:6 Topics: Acetamides; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Heart; Heart Rate; Humans; Isoproterenol; Male; Nadolol; Physical Exertion	1988
Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs. European journal of pharmacology, 1981, Oct-15, Volume: 75, Issue:1 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Dogs; Female; Heart; Heart Rate; Male; Membranes; Myocardial Infarction; Nadolol; Propanolamines; Propranolol	1981
Managing angina with beta blockers. Geriatrics, 1982, Volume: 37, Issue:10 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Humans; Metoprolol; Nadolol; Nitrates; Propanolamines; Propranolol; Timolol	1982
An attempt to characterize the beta-adrenoceptor subtype mediating tail skin temperature response of rats to acute administration of isoproterenol. Pharmacology, 1983, Volume: 27, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Butoxamine; Dose-Response Relationship, Drug; Female; Isoproterenol; Nadolol; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Skin Temperature; Tail	1983
[Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina]. Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1983, Volume: 6, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Echocardiography; Exercise Test; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Nadolol; Propanolamines; Propranolol	1983
Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog. Pharmacology, 1984, Volume: 28, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Dogs; Dose-Response Relationship, Drug; Heart Conduction System; Male; Nadolol; Propanolamines; Propranolol; Sotalol; Ventricular Fibrillation	1984
Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity. Canadian journal of physiology and pharmacology, 1984, Volume: 62, Issue:6 Topics: Acetamides; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Atenolol; Cats; Coronary Circulation; Dogs; Hemodynamics; Isoproterenol; Macaca mulatta; Membranes; Myocardium; Nadolol; Organ Specificity; Oxygen Consumption; Pindolol; Propanolamines; Propranolol; Stroke Volume; Vascular Resistance	1984
Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production. Endocrinology, 1984, Volume: 115, Issue:3 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Dithiothreitol; Liver; Male; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Timolol; Triiodothyronine	1984
Beta-adrenergic blockers. Choosing among them. Postgraduate medicine, 1984, Sep-01, Volume: 76, Issue:3 Topics: Adrenergic beta-Antagonists; Atenolol; Cardiovascular Diseases; Humans; Kinetics; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol	1984
Class III action of beta-blocking agents. Cardiovascular research, 1984, Volume: 18, Issue:11 Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart; Heart Ventricles; Male; Nadolol; Oxprenolol; Pindolol; Propanolamines; Propranolol; Sotalol; Timolol	1984
Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives. Journal of hypertension, 1984, Volume: 2, Issue:1 Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Kidney; Male; Nadolol; Propanolamines; Propranolol; Renin	1984
Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity. Journal of vascular surgery, 1995, Volume: 21, Issue:5 Topics: Animals; Aorta, Thoracic; Aortic Aneurysm; Atenolol; Blood Pressure; Heart Rate; Male; Mice; Mice, Mutant Strains; Nadolol; Propranolol; Protein-Lysine 6-Oxidase	1995
Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:3 Topics: Animals; Atenolol; Cell Division; Immunosuppressive Agents; Leukocyte Count; Leukocytes; Male; Mitogens; Morphine; Nadolol; Propanolamines; Rats; Rats, Inbred Lew; Receptors, Adrenergic, beta; Spleen; Sympathetic Nervous System	1993
Biphasic antagonisms by beta-blockers against positive inotropic response through beta1-adrenoceptors in isolated canine right ventricular muscles: possible involvement of two beta 1-adrenoceptor subtypes. Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:2 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bisoprolol; Dogs; Dose-Response Relationship, Drug; Ethanolamines; Female; Isoproterenol; Male; Myocardial Contraction; Myocardium; Nadolol; Papillary Muscles; Receptors, Adrenergic, beta-1; Stimulation, Chemical	1996
Fluorimetric and solubility studies of nadolol and atenolol in SDS micelles. Journal of pharmaceutical and biomedical analysis, 1998, Volume: 18, Issue:4-5 Topics: Adrenergic beta-Antagonists; Atenolol; Fluorometry; Micelles; Nadolol; Sodium Dodecyl Sulfate; Solubility; Spectrometry, Fluorescence	1998
Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study. Circulation, 1999, May-11, Volume: 99, Issue:18 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Atenolol; Cardiac Catheterization; Chest Pain; Coronary Disease; Coronary Vessels; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Contraction; Nadolol; Norepinephrine; Sympathetic Nervous System; Sympathomimetics	1999
Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation, 1999, Dec-14, Volume: 100, Issue:24 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child; Child, Preschool; Cohort Studies; Death, Sudden; Electric Countershock; Female; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Long QT Syndrome; Male; Metoprolol; Middle Aged; Nadolol; Pacemaker, Artificial; Prognosis; Propranolol; Risk Assessment; Survival Analysis; Treatment Outcome	1999
Partition coefficients of beta-blockers in bile salt/lecithin micelles as a tool to assess the role of mixed micelles in gastrointestinal absorption. Biophysical chemistry, 2001, Mar-15, Volume: 90, Issue:1 Topics: Adrenergic beta-Antagonists; Algorithms; Atenolol; Bile Acids and Salts; Chemical Phenomena; Chemistry, Physical; Indicators and Reagents; Intestinal Absorption; Micelles; Nadolol; Phosphatidylcholines; Potentiometry; Solubility; Solutions; Spectrometry, Fluorescence	2001
Beta blockers normalize QT hysteresis in long QT syndrome. American heart journal, 2002, Volume: 143, Issue:3 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Anti-Arrhythmia Agents; Atenolol; Case-Control Studies; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Long QT Syndrome; Male; Nadolol	2002
The use of multi-frequency EPR techniques to identify the radicals produced in irradiated beta-blockers. Free radical research, 2004, Volume: 38, Issue:1 Topics: Adrenergic beta-Antagonists; Atenolol; Electron Spin Resonance Spectroscopy; Free Radicals; Nadolol; Propanolamines; Propranolol; Temperature	2004
A simple spectrophotometric method for the determination of beta-blockers in dosage forms. Journal of pharmaceutical and biomedical analysis, 2006, Jan-23, Volume: 40, Issue:1 Topics: Adrenergic beta-Antagonists; Atenolol; Bromcresol Purple; Bromphenol Blue; Bromthymol Blue; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chloroform; Coloring Agents; Dose-Response Relationship, Drug; Ions; Kinetics; Models, Chemical; Nadolol; Spectrophotometry, Ultraviolet; Tablets; Thermodynamics; Timolol	2006
Pharmacological treatment of electrical storm in cathecolaminergic polymorphic ventricular tachycardia. Pacing and clinical electrophysiology : PACE, 2010, Volume: 33, Issue:3 Topics: Adolescent; Anti-Arrhythmia Agents; Atenolol; Defibrillators, Implantable; Drug Therapy, Combination; Electrocardiography; Exercise Test; Humans; Male; Nadolol; Quality of Life; Syncope; Tachycardia, Ventricular; Verapamil	2010
Photochemical fate of beta-blockers in NOM enriched waters. The Science of the total environment, 2012, Jun-01, Volume: 426 Topics: Adrenergic beta-Antagonists; Atenolol; Hydrogen-Ion Concentration; Kinetics; Metoprolol; Nadolol; Photochemical Processes; Soil; Sunlight; Water Pollutants, Chemical	2012
A prospective, 1-year follow-up study of postural tachycardia syndrome. Mayo Clinic proceedings, 2012, Volume: 87, Issue:8 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Inflammatory Agents; Atenolol; Cholinesterase Inhibitors; Female; Fludrocortisone; Follow-Up Studies; Heart Rate; Humans; Male; Metoprolol; Midodrine; Nadolol; Norepinephrine; Postural Orthostatic Tachycardia Syndrome; Propranolol; Prospective Studies; Pyridostigmine Bromide; Severity of Illness Index; Sodium; Tilt-Table Test; Virus Diseases	2012
Efficacy of different beta-blockers in the treatment of long QT syndrome. Journal of the American College of Cardiology, 2014, Sep-30, Volume: 64, Issue:13 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Cardiac; Female; Genotype; Heart Arrest; Humans; Infant; Infant, Newborn; Long QT Syndrome; Male; Metoprolol; Multivariate Analysis; Nadolol; Proportional Hazards Models; Propranolol; Registries; Regression Analysis; Risk Factors; Syncope; Time Factors; Treatment Outcome; Young Adult	2014
The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis. The Journal of pharmacy and pharmacology, 2019, Volume: 71, Issue:10 Topics: Antihypertensive Agents; Aryldialkylphosphatase; Atenolol; Atherosclerosis; Humans; Lipoproteins, HDL; Midodrine; Nadolol; Pindolol	2019
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021, Volume: 77, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors	2021
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy. Drug testing and analysis, 2022, Volume: 14, Issue:10 Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry	2022